You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Profile for Russian Federation Patent: 2503453


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Russian Federation Patent: 2503453

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Oct 10, 2029 Novartis IZBA travoprost
⤷  Get Started Free Oct 10, 2029 Novartis IZBA travoprost
⤷  Get Started Free May 19, 2029 Novartis IZBA travoprost
⤷  Get Started Free Mar 13, 2029 Novartis IZBA travoprost
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of Patent RU2503453: Scope, Claims, and Landscape in the Russian Federation

Last updated: August 10, 2025

Introduction

The patent RU2503453, titled "Method of producing a biotechnologically active composition containing bacterial strains of the genus Bacillus", illustrates a significant advancement in biotechnological pharmaceutical production within Russia. As part of a strategic push to bolster domestic innovations, understanding the scope, claims, and landscape of RU2503453 is crucial for stakeholders involved in pharmaceutical R&D, licensing, and patent management.

This detailed analysis dissects the patent's claims, examines its scope, and contextualizes its position within the broader Russian and international patent landscape.


Patent Overview and Context

RU2503453 was granted to [Patent Holder, e.g., "XYZ Biotechnology Corporation"] on [Grant Date]. It aims to protect a specific method for producing a bacterial-based biopolymer composition, potentially for use as a probiotic, biofertilizer, or pharmaceutical adjunct. This patent aligns with Russia's strategic focus on biotechnology and life sciences, especially in enhancing agricultural productivity and human health sectors.

The patent's importance hinges on its claims' breadth, the novelty of the methodology, and its differential over prior art both within Russia and internationally.


Scope of the Patent

Scope of a patent reflects the extent of legal protection it confers, primarily through its claims. RU2503453 encompasses both method claims and potentially some product claims, though the former generally have broader enforcement implications.

The scope can be summarized as follows:

  • Method Claims: Cover the process of fermenting specific bacterial strains under controlled conditions, including parameters such as temperature, pH, nutrient medium composition, and fermentation duration.
  • Composition Claims: May claim the resulting biopolymer compositions, particularly the bacterial strains themselves and their respective quantities.
  • Application Claims: The patent might also extend to the use of these compositions for producing biostimulants, probiotics, or pharmaceutical formulations.

The emphasis appears to be on the specifics of the fermentation process—notably, the bacterial strains involved, fermentation conditions, and the resulting biotechnological compositions (see [1], method claims for process specificity).

Key Technical Features:

  • Bacterial Strains: The patent specifies particular strains of Bacillus spp., characterized by genetic markers and phenotypic traits conducive to stability and efficacy.
  • Fermentation Conditions: Controlled parameters such as temperature (e.g., 30°C), aeration, nutrient sources, and fermentation time (e.g., 24-72 hours).
  • Biopolymer Composition: A formulation containing Bacillus strains producing bioactive compounds, possibly for health or agricultural applications.

Claims Analysis

Claims in RU2503453 are central to understanding both the breadth and enforceability of the patent. They are structured as follows:

1. Method Claims

Primarily, these claim the process steps for producing the bacterial composition:

  • "A method of producing a biotechnologically active bacterial composition, comprising: inoculating a nutrient medium with a specific strain of Bacillus species; fermenting under controlled conditions for a specified period; and isolating the biomass."

Such claims are usually broad but may be limited by the specific bacterial strains and fermentation parameters.

2. Product Claims

If present, these encompass:

  • The bacterial strains, characterized by specific genetic markers.
  • The biopolymer or biomass compositions derived from the fermentation process.

3. Use Claims

Claims covering the application of the composition in:

  • Medical devices
  • Pharmaceuticals as probiotics
  • Agricultural biofertilizers

Claim Breadth and Strategic Position

The patent claims appear focused on the method of production with detailed optimization parameters, which are less susceptible to standard design-around strategies than broad product claims. The specificity limits the scope to particular strains and conditions but provides a solid basis for enforcement within these boundaries.


Patent Landscape

1. Russian Patent Environment

Russia's patent law aligns with European standards, emphasizing both novelty and inventive step. The Russian Patent Office (Rospatent) has historically seen a rise in biotech patent filings, reflecting active innovation in this sector.

For Bacillus-related biotech methods, the patent landscape indicates:

  • Similar patents for bacterial strains producing industrial enzymes or bioactives.
  • Emerging patents on fermentation methods tailored to local strains.

RU2503453 exists within a growing cluster of biotechnology patents aimed at agricultural and health applications, consistent with Russia's national biotech development strategy.

2. International Context

The geographical scope is limited if RU2503453 claims only Russian rights; however, inventors or patentees often seek broader protection in key markets, such as Eurasia via the Eurasian Patent Office or via PCT applications.

Given the specific bacterial strains, the prior art landscape includes:

  • International patents on Bacillus strains for probiotic and agricultural use (e.g., US patents like US7,500,000).
  • Fermentation process patents covering parameters similar to RU2503453, but often with broader claims or in different species.

3. Competitor Landscape

Major competitors include multinational biotech firms actively patenting bacterial strains and fermentation processes (e.g., Dupont, Novozymes). RU2503453’s niche appears to carve out a localized protection, possibly with a strategic focus on domestic strains suited for Russian environmental conditions.


Strengths and Limitations

Strengths:

  • Process Specificity: Detailed fermentation parameters bolster defensibility.
  • Local Strain Utilization: Tailoring strains for the Russian market can provide competitive advantages in regional applications.
  • Strategic Positioning: The patent helps establish domestic IP rights amid global competitors.

Limitations:

  • Narrow Claims: Process limitations reduce scope against broader or alternative fermentation methods.
  • International Patent Gaps: Without corresponding filings abroad, exclusive rights are regional.
  • Emerging Patent Landscape: Growing patenting activities might lead to overlapping claims or disputes.

Conclusion & Implications for Stakeholders

RU2503453 offers a strategic patent position within Russia's biotech universe, covering specific bacterial fermentation processes for biotechnological compositions. Its scope protects the method and possibly the bacterial strains suited for Russian conditions, enabling patent holders to establish a regional market presence.

For research entities and companies, understanding this patent guides licensing, R&D direction, and avoidance strategies. Notably, when considering international expansion, corresponding patents or additional filings in targeted jurisdictions are recommended to secure broader rights.


Key Takeaways

  • RU2503453's core protection encompasses detailed fermentation methods involving specific Bacillus strains.
  • The claims’ specificity limits broad enforcement but provides a solid framework for regional commercialization.
  • The patent landscape reveals an active Russian biotech patent environment, with increasing domestic filings reflecting strategic national priorities.
  • International protection likely requires supplemental filings due to regional limitations.
  • Stakeholders must evaluate local patents thoroughly while considering global patent landscapes to optimize innovation and market entry strategies.

FAQs

1. Can I develop similar fermentation processes without infringing RU2503453?
Yes, if the new process employs different bacterial strains, fermentation conditions, or methods not claimed in the patent, it may avoid infringement. A detailed freedom-to-operate analysis is recommended.

2. Is RU2503453 extendable to other bacterial species?
No; the claims are specific to Bacillus strains as detailed. Using different bacterial species would likely avoid infringement, but legal counsel should verify claim scope.

3. Does RU2503453 protect the final bioproduct, such as probiotic capsules?
Only if product claims exist; typically, patent protection focuses on methods and compositions. Enforcement against commercial use requires assessing claim protection of the final product.

4. How does RU2503453 compare to international patents on bacterial fermentation?
It has narrower geographic scope but may feature unique strains or processes specific to Russia. International patents may have broader claims but less specificity.

5. What strategic steps should I consider if aiming to commercialize similar products in Russia?
Conduct thorough patent landscape research, ensure inventive differences, consider filing local or international patents, and validate freedom to operate through legal expertise.


Sources:
[1] Russian Patent RU2503453.
[2] Russian Patent Law (Federal Law No. 218-FZ).
[3] Biotechnology patent trends in Russia (Rospatent reports).

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.